Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Ewing Sarcoma Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Infoposide, Dactinomycin); By Treatment; By Application; By Region; Segment Forecast, 2023 - 2032
... market size is expected treach USD 424.42 million by 2032, according ta new study by Polaris Market Research. The report “Ewing Syndrome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Vincristine, Cyclophosphamide, ... Read More
-
Global 5-Aminolevulinic Acid Market Insights, Forecast to 2029
... reach a revised size of US$ 321 million by 2029, growing at a CAGR of 8.4% during the forecast period 2023-2029. The global key manufacturers of 5-Aminolevulinic Acid include Sobeo Biotech, Xinlian Biochemical, NMT Biotech, ... Read More
-
Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032
... care market size is expected treach USD 72.87 billion by 2032, according ta new study by Polaris Market Research. The report “Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, ... Read More
-
Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Type (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], and Disease Indication (Early Gastric Cancer and Gastric Cancer Advanced Types)
... (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents ... Read More
-
Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Kaposi Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
... Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others) The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell & gene therapies by class, including early to late clinical stage pipeline products, with a ... Read More
-
Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))
... Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa ... Read More
-
Chemotherapy Induced Anemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Chemotherapy Induced Anemia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Vaginal Cancer Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Vaginal Cancer pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Leuprolide Acetate Market Size, By Application (Cancer [Prostate Cancer, Breast Cancer, Cervix Uteri, Ovary Cancer, Testis], Radical Prostatectomy, Central Precocious Puberty, Endometriosis, Hormone Therapy, Uterine Fibroids), By Product Form (Lyophilized Powder, Pre-Filled Syringes, Vials), By Route Of Administration (Intradermal, Intramuscular, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Route Of Administration (Intradermal, Intramuscular, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Leuprolide Acetate Market is anticipated ... Read More
-
Global Bone Biopsy Market 2023-2027
... on the bone biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
High Intensity Focused Ultrasound (HIFU) Market, By Imaging Technology (Ultrasound- HIFU Therapy, and Magnetic Resonance Imaging- HIFU Therapy), By Indication (Oncology {Prostate cancer, Rectal tumors, Liver tumors, Renal tumors, others}, Skin Care {Anti-aging treatment, Skin Laxity and Tightening, Others}, Neurological Disorders, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics, and Others), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Laxity and Tightening, Others}, Neurological Disorders, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics, and Others), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, ... Read More
-
Breast Cancer Screening Test Market - Growth, Trends, Covid-19 Impact, And Forecasts (2023 - 2028)
... that are responsible for the growth of this market include the increasing awareness about the early detection of breast cancer, the growing incidence of breast cancer, and the increasing government initiatives and support. The Covid-19 ... Read More
-
Breast Implants Market - Global Outlook & Forecast 2023-2028
... breast augmentation is anticipated to provide significant growth to the market. The emergence of under-the-muscle (armpit) breast enlargement, also called transaxillary breast augmentation, has revolutionized the breast implants market as the scar is not visible ... Read More
-
Middle East & Africa Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)
... and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, ... Read More
-
Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell & gene therapies by class, including early to late clinical stage pipeline products, ... Read More
-
Global Fiducial Markers Market - 2023-2030
... CAGR of XX% during the forecast period (2023-2030). Fiducial markers, also referred to as fiducials, are tiny metal implants that are inserted into the body of a patient using a fine needle to direct radiation ... Read More
-
Global Gene Therapy For Cancer Market Growth (Status and Outlook) 2023-2029
... gene expression. LPI (LP Information)' newest research report, the “Gene Therapy For Cancer Industry Forecast” looks at past sales and reviews total world Gene Therapy For Cancer sales in 2022, providing a comprehensive analysis by ... Read More
-
Global Cancer Biomarkers Detection Market Growth (Status and Outlook) 2023-2029
... “Cancer Biomarkers Detection Industry Forecast” looks at past sales and reviews total world Cancer Biomarkers Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Biomarkers Detection sales for ... Read More
-
Europe Liver Cancer Therapeutics Market - 2023-2030
... a CAGR of 8.95% during the forecast period (2023-2030). Liver cancer is a chronic, life-threatening, advanced condition that initiates in liver cells. The liver is the critical organ in the human body, found in the ... Read More
-
Europe Ovarian Cancer Market - 2023-2030
... during the forecast period (2023-2030). Ovarian cancer is a deadly gynecological cancer and is the seventh most common cancer in women globally. Most women with ovarian cancer are diagnosed at the advanced stage, which is ... Read More
-
Global Radiodermatitis Market Size, Trends & Growth Opportunity By Product (Oral, and Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region and Forecast till 2027
... USD 4362.5 million in 2021 which is expected to reach USD 674.22 million by 2027, at a CAGR 9.09 % from 2022-2027. Radiation dermatitis, X-ray dermatitis, and radiation injury are all names for radiodermatitis. It ... Read More
-
Triptorelin Market Size, By Drug (Triptorelin Pamoate, Triptorelin Acetate, Triptorelin Embonate), By Application (Cancer [Prostate Cancer, Breast Cancer, Cervix Uteri, Ovary Cancer, Testis], Radical Prostatectomy, Central Precocious Puberty, Endometriosis, Hormone Therapy, Uterine Fibroids), By Product Form (Lyophilized Powder, Pre-Filled Syringes, Vials), By Route Of Administration (Intradermal, Intramuscular, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Form (Lyophilized Powder, Pre-Filled Syringes, Vials), By Route Of Administration (Intradermal, Intramuscular, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 ... Read More
-
Global Cancer Stem Cell Market Growth (Status and Outlook) 2023-2029
... sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in ... Read More
Research Assistance
